Interleukin-12 Antagonists [MoA] - N0000192796

Pharmacologic Code	N0000192796
Pharmacologic Name	Interleukin-12 Antagonists
Pharmacologic Uses	interleukin-12 antagonist
Pharmacologic Concept	Mechanisms of Action - [MoA]
Pharmacologic Concept Description	This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

The table contains 3 products whose active ingredient are classified under the same pharmacologic class Interleukin-12 Antagonists [MoA].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	57894-054	Stelara	Non-Proprietary Name: Ustekinumab	Solution	Intravenous	Janssen Biotech, Inc.	ACTIVE
	57894-060	Stelara	Non-Proprietary Name: Ustekinumab	Injection, Solution	Subcutaneous	Janssen Biotech, Inc.	ACTIVE
	57894-061	Stelara	Non-Proprietary Name: Ustekinumab	Injection, Solution	Subcutaneous	Janssen Biotech, Inc.	ACTIVE